VR Logo

Mirum Pharmaceuticals Inc. (MIRM) download report


Healthcare | Biotechnology & Pharma Research

Mirum Pharmaceuticals Inc. (MIRM) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

IPO Date: 18-Jul-2019

Pres, CEO & Director: Mr. Christopher Peetz

Chief Financial Officer: Dr. Ian Clements

Listing: NASDAQ: MIRM

Country: United States

Headquarters: Foster City, CA

Website: https://www.mirumpharma.com

Key Facts

Market cap: $638.18 Mln

Revenue (TTM): $32.03 Mln

Earnings (TTM): $-70.06 Mln

Cash: $139.91 Mln

Total Debt: $2.44 Mln

Insider's Holding: 4.69%

Liquidity: Low

52 Week range: $12.82 - 28.65

Shares outstanding: 31,940,800

Stock Performance

Time Period Mirum Pharmaceuticals (MIRM) S&P BSE Sensex* S&P Small-Cap 600*
YTD25.27-8.62-18.78
1 month-19.31-4.54-8.00
3 months-9.26-10.19-13.65
1 Year15.561.43-17.19
3 Years--10.146.10
5 Years--11.265.87
10 Years--11.829.84
As on 01-Jul-2022 *As on 04-Jul-2022
Year Mirum Pharmaceuticals (MIRM) S&P Small-Cap 600 S&P BSE Sensex
2021-8.6525.2721.99
2020-28.799.5715.75